These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22948718)

  • 1. Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.
    Kopkan L; Husková Z; Sporková A; Varcabová Š; Honetschlägerová Z; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Kramer HJ; Bürgelová M; Vojtíšková A; Kujal P; Vernerová Z; Červenka L
    Kidney Blood Press Res; 2012; 35(6):595-607. PubMed ID: 22948718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.
    Honetschlägerová Z; Kitada K; Husková Z; Sporková A; Kopkan L; Bürgelová M; Varcabová Š; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kramer HJ; Kujal P; Vernerová Z; Červenka L
    J Hypertens; 2013 Feb; 31(2):321-32. PubMed ID: 23307303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.
    Sporková A; Jíchová S; Husková Z; Kopkan L; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Cervenka L
    Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1003-13. PubMed ID: 25224811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
    Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.
    Sporková A; Kopkan L; Varcabová S; Husková Z; Hwang SH; Hammock BD; Imig JD; Kramer HJ; Cervenka L
    Am J Physiol Regul Integr Comp Physiol; 2011 Jun; 300(6):R1468-75. PubMed ID: 21411763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and role of soluble epoxide hydrolase in renal tissue of two kidneys one clip hypertension rats model].
    Pan YJ; Tao ZF; Wang Q; Lu M; Guan YF; Zhu Y; Wang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):820-6. PubMed ID: 22178827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
    Neckář J; Kopkan L; Husková Z; Kolář F; Papoušek F; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Malý J; Netuka I; Ošťádal B; Červenka L
    Clin Sci (Lond); 2012 Jun; 122(11):513-25. PubMed ID: 22324471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.
    Hou HH; Hammock BD; Su KH; Morisseau C; Kou YR; Imaoka S; Oguro A; Shyue SK; Zhao JF; Lee TS
    Cardiovasc Res; 2012 Jan; 93(1):120-9. PubMed ID: 22072631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary capsaicin-mediated attenuation of hypertension in a rat model of renovascular hypertension.
    Segawa Y; Hashimoto H; Maruyama S; Shintani M; Ohno H; Nakai Y; Osera T; Kurihara N
    Clin Exp Hypertens; 2020 May; 42(4):352-359. PubMed ID: 31518162
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
    Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension.
    Honetschlägerová Z; Husková Z; Vaňourková Z; Sporková A; Kramer HJ; Hwang SH; Tsai HJ; Hammock BD; Imig JD; Červenka L; Kopkan L
    J Physiol; 2011 Jan; 589(Pt 1):207-19. PubMed ID: 21078594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.
    Kujal P; Čertíková Chábová V; Škaroupková P; Husková Z; Vernerová Z; Kramer HJ; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Kitada K; Nishiyama A; Hwang SH; Hammock BD; Imig JD; Červenka L
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):227-37. PubMed ID: 24471737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial nitric oxide synthase protein is reduced in the renal medulla of two-kidney, one-clip hypertensive rats.
    Wickman A; Andersson IJ; Jia J; Hedin L; Bergström G
    J Hypertens; 2001 Sep; 19(9):1665-73. PubMed ID: 11564988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats.
    Walkowska A; Skaroupková P; Husková Z; Vanourková Z; Chábová VC; Tesar V; Kramer HJ; Falck JR; Imig JD; Kompanowska-Jezierska E; Sadowski J; Cervenka L
    J Hypertens; 2010 Mar; 28(3):582-93. PubMed ID: 19940786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
    Varcabova S; Huskova Z; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Kitada K; Cervenka L
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):273-81. PubMed ID: 23039246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C.
    Helle F; Hultström M; Skogstrand T; Palm F; Iversen BM
    Am J Physiol Renal Physiol; 2009 Jan; 296(1):F78-86. PubMed ID: 18945823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.